Final answer:
The Combat Meth Act regulates only non-prescription products containing pseudoephedrine, which are generally over-the-counter medications, whether as standalone or in combination with other substances. Option c.
Step-by-step explanation:
The Combat Methamphetamine Epidemic Act (CMEA) of 2005 is federal legislation in the United States that regulates the over-the-counter (OTC) sales of pseudoephedrine products. According to the Act, only non-prescription products containing pseudoephedrine are subject to regulation. This includes OTC medications that contain pseudoephedrine, whether sold as single-ingredient formulations or in combination with other drugs, such as antihistamines or pain relievers. The legislation does not cover prescription products containing pseudoephedrine.
The Combat Methamphetamine Epidemic Act (also known as the Combat Meth Act) was passed in 2006 and regulates the sale of non-prescription products containing pseudoephedrine. This includes products like nasal decongestants and cold medicines that contain pseudoephedrine as an active ingredient. However, prescription products containing pseudoephedrine are not subject to this act.